BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25042560)

  • 21. Design and synthesis of novel benzoxazole analogs as Aurora B kinase inhibitors.
    An Y; Lee E; Yu Y; Yun J; Lee MY; Kang JS; Kim WY; Jeon R
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3067-3072. PubMed ID: 27209235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Click chemistry inspired one-pot synthesis of 1,4-disubstituted 1,2,3-triazoles and their Src kinase inhibitory activity.
    Kumar D; Reddy VB; Kumar A; Mandal D; Tiwari R; Parang K
    Bioorg Med Chem Lett; 2011 Jan; 21(1):449-52. PubMed ID: 21084189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-based drug design: Synthesis and biological evaluation of quinazolin-4-amine derivatives as selective Aurora A kinase inhibitors.
    Long L; Wang YH; Zhuo JX; Tu ZC; Wu R; Yan M; Liu Q; Lu G
    Eur J Med Chem; 2018 Sep; 157():1361-1375. PubMed ID: 30196060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SAR156497, an exquisitely selective inhibitor of aurora kinases.
    Carry JC; Clerc F; Minoux H; Schio L; Mauger J; Nair A; Parmantier E; Le Moigne R; Delorme C; Nicolas JP; Krick A; Abécassis PY; Crocq-Stuerga V; Pouzieux S; Delarbre L; Maignan S; Bertrand T; Bjergarde K; Ma N; Lachaud S; Guizani H; Lebel R; Doerflinger G; Monget S; Perron S; Gasse F; Angouillant-Boniface O; Filoche-Rommé B; Murer M; Gontier S; Prévost C; Monteiro ML; Combeau C
    J Med Chem; 2015 Jan; 58(1):362-75. PubMed ID: 25369539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aurora isoform selectivity: design and synthesis of imidazo[4,5-b]pyridine derivatives as highly selective inhibitors of Aurora-A kinase in cells.
    Bavetsias V; Faisal A; Crumpler S; Brown N; Kosmopoulou M; Joshi A; Atrash B; Pérez-Fuertes Y; Schmitt JA; Boxall KJ; Burke R; Sun C; Avery S; Bush K; Henley A; Raynaud FI; Workman P; Bayliss R; Linardopoulos S; Blagg J
    J Med Chem; 2013 Nov; 56(22):9122-35. PubMed ID: 24195668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of novel 2,4,5-triarylimidazole-1,2,3-triazole derivatives via click chemistry as α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li J; Li X
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5719-5723. PubMed ID: 27810241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of 3,5,6-substituted indolin-2-one's inhibitors of Aurora B by development of a luminescent kinase assay.
    Zhang L; Yang T; Xie X; Liu G
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2937-42. PubMed ID: 26048792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors.
    Luo Y; Deng YQ; Wang J; Long ZJ; Tu ZC; Peng W; Zhang JQ; Liu Q; Lu G
    Eur J Med Chem; 2014 May; 78():65-71. PubMed ID: 24681066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyrazolo[4,3-b]pyrimido[4,5-e][1,4]diazepine derivatives as new multi-targeted inhibitors of Aurora A/B and KDR.
    Zhang Q; Shen Q; Gao L; Tong L; Li J; Chen Y; Lu W
    Eur J Med Chem; 2018 Oct; 158():428-441. PubMed ID: 30241010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, biological activity evaluation of 3-(4-phenyl-1H-imidazol-2-yl)-1H-pyrazole derivatives as potent JAK 2/3 and aurora A/B kinases multi-targeted inhibitors.
    Zheng YG; Wang JA; Meng L; Pei X; Zhang L; An L; Li CL; Miao YL
    Eur J Med Chem; 2021 Jan; 209():112934. PubMed ID: 33109396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dual aurora and lim kinase inhibitor reduces glioblastoma proliferation and invasion.
    Rybin MJ; Laverde-Paz MJ; Suter RK; Affer M; Ayad NG; Feng Y; Zeier Z
    Bioorg Med Chem Lett; 2022 Apr; 61():128614. PubMed ID: 35151865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug design.
    Chang CF; Lin WH; Ke YY; Lin YS; Wang WC; Chen CH; Kuo PC; Hsu JTA; Uang BJ; Hsieh HP
    Eur J Med Chem; 2016 Nov; 124():186-199. PubMed ID: 27573544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery and Synthesis of a Pyrimidine-Based Aurora Kinase Inhibitor to Reduce Levels of MYC Oncoproteins.
    Chi YH; Yeh TK; Ke YY; Lin WH; Tsai CH; Wang WP; Chen YT; Su YC; Wang PC; Chen YF; Wu ZW; Yeh JY; Hung MC; Wu MH; Wang JY; Chen CP; Song JS; Shih C; Chen CT; Chang CP
    J Med Chem; 2021 Jun; 64(11):7312-7330. PubMed ID: 34009981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery and optimization of novel benzothiophene-3-carboxamides as highly potent inhibitors of Aurora kinases A and B.
    Gyulavári P; Szokol B; Szabadkai I; Brauswetter D; Bánhegyi P; Varga A; Markó P; Boros S; Illyés E; Szántai-Kis C; Krekó M; Czudor Z; Őrfi L
    Bioorg Med Chem Lett; 2018 Oct; 28(19):3265-3270. PubMed ID: 30143423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ynamide Click chemistry in development of triazole VEGFR2 TK modulators.
    Vojtičková M; Dobiaš J; Hanquet G; Addová G; Cetin-Atalay R; Yildirim DC; Boháč A
    Eur J Med Chem; 2015 Oct; 103():105-22. PubMed ID: 26344911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery and optimization of novel phenyldiazepine and pyridodiazepine based Aurora kinase inhibitors.
    Tamizharasan N; Gajendran C; Kristam R; Sulochana SP; Sivanandhan D; Mullangi R; Mathivathanan L; Hallur G; Suresh P
    Bioorg Chem; 2020 Jun; 99():103800. PubMed ID: 32283344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SERS and MD simulation studies of a kinase inhibitor demonstrate the emergence of a potential drug discovery tool.
    Karthigeyan D; Siddhanta S; Kishore AH; Perumal SS; Ågren H; Sudevan S; Bhat AV; Balasubramanyam K; Subbegowda RK; Kundu TK; Narayana C
    Proc Natl Acad Sci U S A; 2014 Jul; 111(29):10416-21. PubMed ID: 24972791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioactive compounds of Eriocaulon sieboldianum blocking proliferation and inducing apoptosis of HepG2 cells might be involved in Aurora kinase inhibition.
    Fan Y; Lu H; Ma H; Feng F; Hu X; Zhang Q; Wang J; Xu Y; Zhao Q
    Food Funct; 2015 Dec; 6(12):3746-59. PubMed ID: 26369427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of 2,4-diaminopyrimidines as selective Aurora A kinase inhibitors.
    Qin WW; Sang CY; Zhang LL; Wei W; Tian HZ; Liu HX; Chen SW; Hui L
    Eur J Med Chem; 2015 May; 95():174-84. PubMed ID: 25812967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The synthesis and anti-tumour properties of novel 4-substituted phthalazinones as Aurora B kinase inhibitors.
    Zhang XJ; Xu Y; Mou HX; Wang S; Hao SY; Chen SW
    Bioorg Med Chem Lett; 2020 Dec; 30(23):127556. PubMed ID: 32941989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.